Sterne Agee Starts Actavis (ACT) at Buy
Tweet
Share
E-mailGet Alerts ACT Hot Sheet
Price: $49.94 +0.32%
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Sterne Agee initiated coverage on Actavis (NYSE: ACT) with a Buy rating and a price target of $230.00.
For an analyst ratings summary and ratings history on Actavis click here. For more ratings news on Actavis click here.
Shares of Actavis closed at $193.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enact Holdings Inc (ACT) PT Raised to $49 at Keefe, Bruyette & Woods
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
Create E-mail Alert Related Categories
New CoverageRelated Entities
Sterne AgeeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
